Filing Details
- Accession Number:
- 0001437749-21-023912
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-19 16:56:06
- Reporting Period:
- 2021-10-19
- Accepted Time:
- 2021-10-19 16:56:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 946486 | Windtree Therapeutics Inc | WINT | Biological Products, (No Disgnostic Substances) (2836) | 943171943 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1573160 | James Huang | C/O Windtree Therapeutics, Inc. 2600 Kelly Road, Suite 100 Warrington PA 18976 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-10-19 | 50,000 | $1.90 | 291,281 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,336,853 | Indirect | Via Panacea Venture Healthcare Fund I L.P. |
Footnotes
- The shares were purchased in multiple trades at prices ranging from $1.84 to $1.93. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The Reporting Person is a Director of Panacea Venture Healthcare Fund GP I L.P. The Reporting Person disclaims beneficial ownership of the shares held by Panacea Venture Healthcare Fund I L.P., except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
